Anti-phosphatidylserine-prothrombin antibodies are associated with outcome in aTIA cohort

Frontiers in Neurology

Volumn SEP, Issue , 2012, Pages

  Mullen, Michael T ^a   Messé, Steven R ^a   Kasner, Scott E ^a   Sansing, Lauren ^b   Husain, M R ^a   Norman, Gary L ^c   Shums, Zakera ^c   Cucchiara, Brett L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c INOVA DIAGNOSTICS INC   (United States)

Author keywords

Anticardiolipin; Antiphospholipid; APS PT antibodies; Biomarker; Infarction; Thrombosis; Transient ischemic attack

Indexed keywords

EID: 84867113119     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00137     Document Type: Article

References (32)

1. Atsumi, T., Ieko, M., Bertolaccini, M. L., Ichikawa, K., Tsutsumi, A., Matsuura, E., and Koike, T. (2000). Association of autoantibodies against the phosphatidylserineprothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 43, 1982-1993.
2. Audrain, M. A., Colonna, F., Morio, F., Hamidou, M. A., and Muller, J. Y. (2004). Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1. Rheumatology (Oxford) 43, 181-185.
3. Avalos, I., and Tsokos, G. C. (2009). The role of complement in the antiphospholipid syndromeassociated pathology. Clin. Rev. Allergy Immunol. 36, 141-144.
4. Bertolaccini, M., Amengual, O., Atsumi, T., Binder, W., Laat, B. D., Forastiero, R., Kutteh, W., Lambert, M., Matsubayashi, H., Murthy, V., Petri, M., Rand, J., Sanmarco, M., Tebo, A., and Pierangeli, S. (2011). 'Noncriteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 20, 191-205.
5. Bertolaccini, M. L., Atsumi, T., Koike, T., Hughes, G. R. V., and Khamashta, M. A. (2005). Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb. Haemost. 93, 289-297.
6. Bizzaro, N., Ghirardello, A., Zampieri, S., Iaccarino, L., Tozzoli, R., Ruffatti, A., Villalta, D., Tonutti, E., and Doria, A. (2007). Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. J. Thromb. Haemost. 5, 1158-1164.
7. Bizzaro, N. C. M., Villalta, D., Antico, A., Tonutti, E., and Tozzoli, R. (2010). "Antibodies to the B2GP1 domains IV/V in patients with stroke and acute coronary syndrome: results of a prospective case-control study," in Autoimmune Congress. [Abstr.]
8. Brey, R. L., Abbott, R. D., Curb, J. D., Sharp, D. S., Ross, G. W., Stallworth, C. L., and Kittner, S. J. (2001). beta(2)-Glycoprotein 1dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program. Stroke 32, 1701-1706
9. Cohen,D.,Berger,S. P.,Steup-Beekman, G. M., Bloemenkamp, K. W. M., and Bajema, I. M. (2010). Diagnosis and management of the antiphospholipid syndrome. BMJ 340, c2541- c2541.
10. Cucchiara,B.L.,Messe,S. R.,Sansing,L., MacKenzie, L., Taylor, R. A., Pacelli, J., Shah, Q., Pollak, E. S., and Kasner, S. E. (2009). D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification. J. Stroke Cerebrovasc. Dis. 18, 367-373.
11. Cucchiara, B. L., Messe, S. R., Taylor, R. A., Pacelli, J., Maus, D., Shah, Q., and Kasner, S. E. (2006). Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke 37, 1710-1714.
12. Easton, J. D., Saver, J. L., Albers, G. W., Alberts, M. J., Chaturvedi, S., Feldmann, E., Hatsukami, T. S., Higashida, R. T., Johnston, S. C., Kidwell, C. S., Lutsep, H. L., Miller, E., and Sacco, R. L. (2009). Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke 40, 2276-2293
13. Farsi, A., Domeneghetti, M. P., Fedi, S., Capanni, M., Giusti, B., Marcucci, R., Giurlani, L., Prisco, D., Passaleva, A., Gensini, G. F., and Abbate, R. (1999). High prevalence of antibeta2 glycoprotein I antibodies in patients with ischemic heart disease. Autoimmunity 30, 93-98.
14. Forastiero, R., Martinuzzo, M., Pombo, G., Puente, D., Rossi, A., Celebrin, L., Bonaccorso, S., and Aversa, L. (2005). A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. J. Thromb. Haemost. 3, 1231-1238.
15. Franck, M., Staub, H. L., Petracco, J. B., Norman, G. L., Lassen, A. J., Schiavo, N., Borges, R. B., and Von Muhlen, C. A. (2007). Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease. Angiology 58, 295-302.
16. George, J., Harats, D., Gilburd, B., Afek, A., Levy, Y., Schneiderman, J., Barshack, I., Kopolovic, J., and Shoenfeld, Y. (1999). Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation 99, 2227-2230.
17. Giles, M. F., Albers, G. W., Amarenco, P., Arsava, E. M., Asimos, A. W., Ay, H., Calvet,D.,Coutts,S. B.,Cucchiara,B. L., Demchuk, A. M., Johnston, S. C., Kelly, P. J., Kim, A. S., Labreuche, J., Lavallee,P. C.,Mas,J. L.,Merwick,A., Olivot, J. M., Purroy, F., Rosamond, W. D., Sciolla, R., and Rothwell, P. M. (2011). Early stroke risk and ABCD2 score performance in tissuevs. time-defined TIA: a multicenter study. Neurology 77, 1222-1228.
18. Horstman, L. L., Jy, W., Bidot, C. J., Ahn, Y. S., Kelley, R. E., Zivadinov, R., Maghzi, A. H., Etemadifar, M., Mousavi, S., and Minagar, A. (2009). Antiphospholipid antibodies: paradigm in transition. J. Neuroinflam- mation 6, 3.
19. Iverson, G. M., Von Mühlen, C. A., Staub, H. L., Lassen, A. J., Binder,W., and Norman, G. L. (2006). Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of β2-GPI. J. Autoimmun. 27, 266-271.
20. Johnston, S. C., Rothwell, P. M., Nguyen-Huynh, M. N., Giles, M. F., Elkins, J. S., Bernstein,A. L., and Sidney, S. (2007). Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369, 283-292.
21. Kleindorfer, D., Panagos, P., Pancioli, A., Khoury, J., Kissela, B., Woo, D., Schneider, A., Alwell, K., Jauch, E., Miller, R., Moomaw, C., Shukla, R., and Broderick, J. P. (2005). Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 36, 720-723.
22. Levine, S. R., Brey, R. L., Tilley, B. C., Thompson, J. L., Sacco, R. L., Sciacca, R. R., Murphy, A., Lu, Y., Costigan, T. M., Rhine, C., Levin, B., Triplett,D. A.,and Mohr,J. P. (2004). Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 291, 576-584.
23. Matsuura, E., Kobayashi, K., Koike, T., and Shoenfeld, Y. (2002). Autoantibody-mediated atherosclerosis. Autoimmun. Rev. 1, 348-353.
24. Matsuura, E., Kobayashi, K., Koike, T., Shoenfeld,Y.,Khamashta,M. A.,and Hughes, G. R. (2003). Oxidized lowdensity lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. Lupus 12, 550-554.
25. Merwick, A., Albers, G. W., Amarenco, P., Arsava, E. M., Ay, H., Calvet, D., Coutts, S. B., Cucchiara, B. L., Demchuk, A. M., Furie, K. L., Giles, M. F., Labreuche, J., Lavallee, P. C., Mas, J. L., Olivot, J. M., Purroy, F., Rothwell, P. M., Saver, J. L., Sheehan, O. C., Stack, J. P., Walsh, C., and Kelly, P. J. (2010). Addition of brain and carotid imaging to the ABCD(2) score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol. 9, 1060-1069.
26. Okuma, H., Kitagawa, Y., Kobori, S., Sekiyama, S., and Takagi, S. (2006). Prevalence rates of antiphospholipid antibodies in ischemic stroke patients. Intern. Med. 45,1017-1018.
27. Perry, J. J., Sharma, M., Sivilotti, M. L., Sutherland, J., Symington, C., Worster, A., Emond, M., Stotts, G., Jin, A. Y., Oczkowski, W. J., Sahlas, D. J., Murray, H. E., MacKey, A., Verreault, S., Wells, G. A., and Stiell, I. G. (2011). Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack. CMAJ 183, 1137-1145.
28. Rand, J. H. (2000). Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. J. Autoimmun. 15, 107-111.
29. Sanmarco, M., Gayet, S., Alessi, M. C., Audrain, M., De Maistre, E., Gris, J. C., De Groot, P. G., Hachulla, E., Harle, J. R., Sie, P., and Boffa, M. C. (2007). Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb. Haemost. 97, 949-954.
30. Staub, H. L., Franck, M., Ranzolin, A., Norman, G. L., Iverson, G. M., and Von Mühlen, C. A. (2006). IgA antibodies to beta2-glycoprotein I and atherosclerosis. Autoimmun. Rev. 6, 104-106.
31. Staub, H. L., Norman, G. L., Crowther, T., Da Cunha, V. R., Polanczyk, A., Bohn, J. M., Fernandes, J. G., Chahade, W. H., and Von Muhlen, C. A. (2003). Antibodies to the atherosclerotic plaque components beta2glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischemia. Arq. Neuropsiquiatr. 61, 757-763.
32. Veres, K., Lakos, G., Kerenyi, A., Szekanecz, Z., Szegedi, G., Shoenfeld, Y., and Soltesz, P. (2004). Antiphospholipid antibodies in acute coronary syndrome. Lupus 13, 423-427.